Novel liposome composition for sustained release of steroidal drugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5043165
SERIAL NO

07284216

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a novel, non-conventional liposome formulation for the sustained release and delivery of steroids. The formulation provides prolonged release of the drug, improved therapeutic ratio, lower toxicity, reduced systemic side effects and is stable for up to three months. The formulation is suitable for sustained delivery of steroid via inhalation, parenteral, intrathecal, intraarticular, topical, ophthalmic, and oral administration.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LIPOSOME TECHNOLOGY INC A CORP OF CA1050 HAMILTON COURT MENLO PARK CA 94025

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Radhakrishnan, Ramachandran Fremont, CA 46 1795

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation